Activity and expression of different members of the caspase family in the rat corpus luteum during pregnancy and postpartum

Marina C. Peluffo, Richard Stouffer, Marta Tesone

    Research output: Contribution to journalArticle

    9 Citations (Scopus)

    Abstract

    Studies were designed to examine the expression and activity of four caspases that contribute to the initial (caspases-2, -8, and -9) and final (caspase-3) events in apoptosis in the rat corpus luteum (CL) during pregnancy (days 7, 17, 19, and 21 of gestation), postpartum (days 1 and 4), and after injection (0, 8, 16, 24, and 36 h) of the physiological luteolysin PGF2α. In addition, the temporal relationship of caspase expression/activity relative to steroid production and luteal regression was evaluated. During pregnancy, the activity of all four caspases was significantly greater on day 19, before a decline in CL progesterone (P) and CYP11A1 levels at day 21 of gestation. The levels of the caspase-3 active fragment (p17, measured by Western blot) also increased at days 19 and 21 of pregnancy. Immunohistochemical analyses detected specific staining for the caspases in luteal cells (large and small) as well as in endothelial cells. However, the percentage of apoptotic cells did not increase in the CL until postpartum. Following PGF2α injection, there was a significant decrease in CL P by 24 h, although the activity of all four caspases did not increase until 36 h posttreatment. The active p17 fragment of caspase-3 also significantly increased at 36 h post-PGF2α. These results suggest that an increase in the activity of caspases-2, -8, -9, and -3 is associated with the early events of natural luteolysis at the end of pregnancy. Also, the exogenous administration of the luteolysin PGF2α may regulate members of the caspase family.

    Original languageEnglish (US)
    JournalAmerican Journal of Physiology - Endocrinology and Metabolism
    Volume293
    Issue number5
    DOIs
    StatePublished - Nov 2007

    Fingerprint

    Corpus Luteum
    Caspases
    Postpartum Period
    Rats
    Dinoprost
    Pregnancy
    Caspase 3
    Caspase 2
    Luteolysis
    Luteal Cells
    Caspase 8
    Cholesterol Side-Chain Cleavage Enzyme
    Injections
    Endothelial cells
    Progesterone
    Endothelial Cells
    Western Blotting
    Steroids
    Cells
    Apoptosis

    Keywords

    • Apoptosis
    • Luteolysis

    ASJC Scopus subject areas

    • Physiology
    • Endocrinology
    • Biochemistry

    Cite this

    @article{0a51bae3d2d947e58a50b92b9b31bc2c,
    title = "Activity and expression of different members of the caspase family in the rat corpus luteum during pregnancy and postpartum",
    abstract = "Studies were designed to examine the expression and activity of four caspases that contribute to the initial (caspases-2, -8, and -9) and final (caspase-3) events in apoptosis in the rat corpus luteum (CL) during pregnancy (days 7, 17, 19, and 21 of gestation), postpartum (days 1 and 4), and after injection (0, 8, 16, 24, and 36 h) of the physiological luteolysin PGF2α. In addition, the temporal relationship of caspase expression/activity relative to steroid production and luteal regression was evaluated. During pregnancy, the activity of all four caspases was significantly greater on day 19, before a decline in CL progesterone (P) and CYP11A1 levels at day 21 of gestation. The levels of the caspase-3 active fragment (p17, measured by Western blot) also increased at days 19 and 21 of pregnancy. Immunohistochemical analyses detected specific staining for the caspases in luteal cells (large and small) as well as in endothelial cells. However, the percentage of apoptotic cells did not increase in the CL until postpartum. Following PGF2α injection, there was a significant decrease in CL P by 24 h, although the activity of all four caspases did not increase until 36 h posttreatment. The active p17 fragment of caspase-3 also significantly increased at 36 h post-PGF2α. These results suggest that an increase in the activity of caspases-2, -8, -9, and -3 is associated with the early events of natural luteolysis at the end of pregnancy. Also, the exogenous administration of the luteolysin PGF2α may regulate members of the caspase family.",
    keywords = "Apoptosis, Luteolysis",
    author = "Peluffo, {Marina C.} and Richard Stouffer and Marta Tesone",
    year = "2007",
    month = "11",
    doi = "10.1152/ajpendo.00261.2007",
    language = "English (US)",
    volume = "293",
    journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
    issn = "1931-857X",
    publisher = "American Physiological Society",
    number = "5",

    }

    TY - JOUR

    T1 - Activity and expression of different members of the caspase family in the rat corpus luteum during pregnancy and postpartum

    AU - Peluffo, Marina C.

    AU - Stouffer, Richard

    AU - Tesone, Marta

    PY - 2007/11

    Y1 - 2007/11

    N2 - Studies were designed to examine the expression and activity of four caspases that contribute to the initial (caspases-2, -8, and -9) and final (caspase-3) events in apoptosis in the rat corpus luteum (CL) during pregnancy (days 7, 17, 19, and 21 of gestation), postpartum (days 1 and 4), and after injection (0, 8, 16, 24, and 36 h) of the physiological luteolysin PGF2α. In addition, the temporal relationship of caspase expression/activity relative to steroid production and luteal regression was evaluated. During pregnancy, the activity of all four caspases was significantly greater on day 19, before a decline in CL progesterone (P) and CYP11A1 levels at day 21 of gestation. The levels of the caspase-3 active fragment (p17, measured by Western blot) also increased at days 19 and 21 of pregnancy. Immunohistochemical analyses detected specific staining for the caspases in luteal cells (large and small) as well as in endothelial cells. However, the percentage of apoptotic cells did not increase in the CL until postpartum. Following PGF2α injection, there was a significant decrease in CL P by 24 h, although the activity of all four caspases did not increase until 36 h posttreatment. The active p17 fragment of caspase-3 also significantly increased at 36 h post-PGF2α. These results suggest that an increase in the activity of caspases-2, -8, -9, and -3 is associated with the early events of natural luteolysis at the end of pregnancy. Also, the exogenous administration of the luteolysin PGF2α may regulate members of the caspase family.

    AB - Studies were designed to examine the expression and activity of four caspases that contribute to the initial (caspases-2, -8, and -9) and final (caspase-3) events in apoptosis in the rat corpus luteum (CL) during pregnancy (days 7, 17, 19, and 21 of gestation), postpartum (days 1 and 4), and after injection (0, 8, 16, 24, and 36 h) of the physiological luteolysin PGF2α. In addition, the temporal relationship of caspase expression/activity relative to steroid production and luteal regression was evaluated. During pregnancy, the activity of all four caspases was significantly greater on day 19, before a decline in CL progesterone (P) and CYP11A1 levels at day 21 of gestation. The levels of the caspase-3 active fragment (p17, measured by Western blot) also increased at days 19 and 21 of pregnancy. Immunohistochemical analyses detected specific staining for the caspases in luteal cells (large and small) as well as in endothelial cells. However, the percentage of apoptotic cells did not increase in the CL until postpartum. Following PGF2α injection, there was a significant decrease in CL P by 24 h, although the activity of all four caspases did not increase until 36 h posttreatment. The active p17 fragment of caspase-3 also significantly increased at 36 h post-PGF2α. These results suggest that an increase in the activity of caspases-2, -8, -9, and -3 is associated with the early events of natural luteolysis at the end of pregnancy. Also, the exogenous administration of the luteolysin PGF2α may regulate members of the caspase family.

    KW - Apoptosis

    KW - Luteolysis

    UR - http://www.scopus.com/inward/record.url?scp=36148935569&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=36148935569&partnerID=8YFLogxK

    U2 - 10.1152/ajpendo.00261.2007

    DO - 10.1152/ajpendo.00261.2007

    M3 - Article

    VL - 293

    JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

    JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

    SN - 1931-857X

    IS - 5

    ER -